|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.553
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.532
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.507
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.446
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.423
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.403
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.384
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.356
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.353
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.338
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.335
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.303
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.300
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.270
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.254
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.248
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.241
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.238
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.236
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.232
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.231
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.220
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.218
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.211
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.206
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.201
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.196
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.196
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.174
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.173
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.173
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.171
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.164
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.163
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.159
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.156
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.155
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.152
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.149
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.147
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.140
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.138
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.135
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.133
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.133
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.130
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.128
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.128
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.127
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.125
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.125
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.124
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.123
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.123
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.123
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.122
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.122
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.120
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.118
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.117
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.116
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.115
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.115
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.115
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.114
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.111
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.110
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.108
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.108
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.104
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.104
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.103
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.103
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.101
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.098
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.097
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.097
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.096
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.096
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.096
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.095
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.095
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.094
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.093
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.092
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.092
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.089
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.089
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.088
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.088
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.088
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.087
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.087
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.087
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.085
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.084
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.084
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.084
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.083
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.082
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.082
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.082
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.082
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.081
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.080
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.080
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.079
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.079
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.078
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.078
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.077
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.077
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.077
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.076
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.076
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.075
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.075
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.074
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.074
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.074
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.073
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.072
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.072
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.072
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.072
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.071
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.069
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.069
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.069
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.069
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.068
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.068
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.068
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.068
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.066
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.066
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.066
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.066
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.065
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.065
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.065
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.064
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.064
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.062
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.062
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.061
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.060
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.060
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.060
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.059
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.059
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.059
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.058
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.058
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.058
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.057
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.057
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.057
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.056
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.056
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.056
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.056
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.056
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.056
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.056
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.054
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.054
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.054
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.054
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.053
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.053
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.053
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.053
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.052
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.052
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.051
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.051
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.051
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.051
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.050
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.049
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.049
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.049
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.048
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.048
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.048
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.048
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.048
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.048
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.048
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.047
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.047
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.047
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.047
|
|
|
|
learning
|
GO:0007612 |
98 |
0.047
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.046
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.046
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.046
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.046
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.046
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.046
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.046
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.045
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.045
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.045
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.045
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.045
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.045
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.045
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.045
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.044
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.044
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.043
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.043
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.043
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.043
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.043
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.043
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.042
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.042
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.042
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.042
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.042
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.041
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.041
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.041
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.041
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.041
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.041
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.041
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.041
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.041
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.041
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.040
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.040
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.040
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.040
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.040
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.040
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.040
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.040
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.040
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.040
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.039
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.039
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.039
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.039
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.039
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.039
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.039
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.039
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.038
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.038
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.038
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.038
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.038
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.038
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.037
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.037
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.037
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.037
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.037
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.037
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.036
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.036
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.036
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.036
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.036
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.036
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.036
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.035
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.035
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.035
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.035
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.034
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.034
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.034
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.034
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.034
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.034
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.034
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.034
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.034
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.034
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.034
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.033
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.033
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.033
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.033
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.033
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.033
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.033
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.032
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.032
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.032
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.032
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.032
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
3 |
0.032
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.031
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.031
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.031
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.031
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.031
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.031
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.031
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.031
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.031
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.030
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.030
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.030
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.030
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.030
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.030
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.030
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.030
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.030
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.030
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.030
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.029
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.029
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.029
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.029
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.029
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.029
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.029
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.029
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.029
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.029
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.029
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.028
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.028
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.028
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.028
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.028
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.028
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.028
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.028
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.028
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.028
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.027
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.027
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.027
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.027
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.027
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.027
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.027
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.027
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.027
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.027
|
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
35 |
0.026
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.026
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.026
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.026
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.026
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.026
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.026
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.026
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.026
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.026
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.026
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.026
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.025
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.025
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.025
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.025
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.025
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.025
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.025
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.025
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.025
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.025
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.025
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.025
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.025
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.024
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.024
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.024
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.024
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.024
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.024
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.024
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.024
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.024
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
|
|
|
negative regulation of bone trabecula formation
|
GO:1900155 |
1 |
0.024
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.024
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.024
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.024
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.024
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.024
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.024
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.024
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.024
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.023
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.023
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.023
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.023
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.023
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.023
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.023
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.023
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.023
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.023
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.023
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.023
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.023
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.023
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.023
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.023
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.022
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.022
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.022
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.022
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.022
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.022
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.022
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.022
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.022
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.022
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.022
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.022
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.022
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.022
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.022
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.021
|
|
|
|
dorsal spinal cord development
|
GO:0021516 |
20 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.021
|
|
|
|
entry into host
|
GO:0044409 |
15 |
0.021
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.021
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.021
|
|
|
|
cellular response to prostaglandin d stimulus
|
GO:0071799 |
1 |
0.021
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.021
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.021
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.021
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.021
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.021
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.021
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.021
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.021
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.020
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.020
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.020
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.020
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.020
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.020
|
|
